Individual Stock News
1. CATL (03750.HK) announced its 2025 results: net profit attributable to shareholders of approximately RMB 72.201 billion, a year-on-year increase of 42.28%, with a cash dividend of RMB 69.57 per 10 shares.
2. Huicai Holdings (01180.HK) issued a profit warning: 2025 profit is expected to decrease by 63.5% year-on-year.
3. Tanwan (09890.HK) issued a profit alert: 2025 net profit is expected to increase significantly to no less than RMB 1.5 billion.
4. China Nuclear Energy Technology (00611.HK) issued a profit alert: 2025 net profit is expected to increase by approximately 40% to 50% year-on-year.
5. Huaxian Optoelectronics (00334.HK): A subsidiary plans to acquire equipment and machinery for the production of LCD modules for RMB 33.268 million.
6. China Jinmao (00817.HK): Contracted sales amounted to RMB 12.93 billion in the first two months, a year-on-year increase of 16.37%.
7. Ziyuanyuan (08223.HK): Plans to issue 86 million subscription shares at a discount of approximately 9.09%, raising net proceeds of approximately HKD 42.5 million.
8. Huaxian Optoelectronics (00334.HK) issued a profit warning: It expects profit attributable to owners of the parent company to increase by no less than 80% year-on-year in 2025.
9. Fosun Pharma (02696.HK): The clinical trial application for HLX3901 injection in patients with advanced/metastatic solid tumors has been approved by the National Medical Products Administration.
10. Junshi Biosciences (01877.HK): The marketing application for toripalimab injection (subcutaneous injection) has been accepted.
